$169.182,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Dr. Gilligan has recruited global experts to contribute articles on the topic of testes cancer. The issue is organized to mimic the clinical process of detection, treatment, and management. Included in the issue are articles on the biology, interpretation, and imaging of germ cell tumors; early stage and stage II of seminomas and nonseminomas; first, second, and third line of chemotherapy for disseminated germ cell tumors, resection of residual masses, and treatment of brain metastases.

1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Preface - p. 5 6. Biology of Germ Cell Tumors - p. 6 7. Etiologic Differences Between Seminoma and Nonseminoma of the Testis: A Systematic Review of Epidemiologic Studies - p. 12 8. Imaging Studies for Germ Cell Tumors - p. 19 9. Management of Stage I Testicular Seminoma - p. 27 10. Stage I Nonseminomatous Germ Cell Tumor of the Testis: More Questions than Answers? - p. 35 11. Stage II Seminomas and Nonseminomas - p. 42 12. First-Line Chemotherapy of Disseminated Germ Cell Tumors - p. 49 13. A Review of Second-line Chemotherapy and Prognostic Models for Disseminated Germ Cell Tumors - p. 57 14. Third-Line Chemotherapy and Novel Agents for Metastatic Germ Cell Tumors - p. 69 15. Role of Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors - p. 77 16. Treatment of Brain Metastases from Germ Cell Tumors - p. 82 17. Late Relapse of Germ Cell Tumors - p. 88 18. Testicular Cancer Survivorship - p. 96 19. Index - p. 105

Descripcion
Descripción

Dr. Gilligan has recruited global experts to contribute articles on the topic of testes cancer. The issue is organized to mimic the clinical process of detection, treatment, and management. Included in the issue are articles on the biology, interpretation, and imaging of germ cell tumors; early stage and stage II of seminomas and nonseminomas; first, second, and third line of chemotherapy for disseminated germ cell tumors, resection of residual masses, and treatment of brain metastases.

1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Preface - p. 5 6. Biology of Germ Cell Tumors - p. 6 7. Etiologic Differences Between Seminoma and Nonseminoma of the Testis: A Systematic Review of Epidemiologic Studies - p. 12 8. Imaging Studies for Germ Cell Tumors - p. 19 9. Management of Stage I Testicular Seminoma - p. 27 10. Stage I Nonseminomatous Germ Cell Tumor of the Testis: More Questions than Answers? - p. 35 11. Stage II Seminomas and Nonseminomas - p. 42 12. First-Line Chemotherapy of Disseminated Germ Cell Tumors - p. 49 13. A Review of Second-line Chemotherapy and Prognostic Models for Disseminated Germ Cell Tumors - p. 57 14. Third-Line Chemotherapy and Novel Agents for Metastatic Germ Cell Tumors - p. 69 15. Role of Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors - p. 77 16. Treatment of Brain Metastases from Germ Cell Tumors - p. 82 17. Late Relapse of Germ Cell Tumors - p. 88 18. Testicular Cancer Survivorship - p. 96 19. Index - p. 105

Indice
Autores
Muestra
Ficha Técnica